Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
OVERLAP
24%
OVERLAP
BY WEIGHT
33
# OF OVERLAPPING
HOLDINGS
CANC
56
HOLDINGS
59%
ALSO IN XBI
XBI
139
HOLDINGS
25%
ALSO IN CANC
SECTOR DRIFT (CANC minus XBI)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in CANC |
Weight in XBI |
Overlap | |
|---|---|---|---|---|
| REVOLUTION MEDICINES, INC. | 7.1% | 1.8% | 1.8% | |
| HALOZYME THERAPEUTICS INC | 1.4% | 1.3% | 1.3% | |
| AMGEN INC | 2.5% | 1.3% | 1.3% | |
| CELCUITY INC. | 2.5% | 1.3% | 1.3% | |
| EXELIXIS INC | 2.3% | 1.3% | 1.3% | |
CANC Overweight Relative to XBI
| REVOLUTION MEDICINES, INC. | 5.3% | |
| NOVARTIS AG | 4.4% | |
| ELI LILLY & CO | 4.2% | |
| ASTRAZENECA PLC | 4.2% | |
| ROCHE HOLDINGS LTD-SPONS ADR | 4.1% | |
| BRISTOL-MYERS SQUIBB CO | 3.8% | |
| MERCK & CO. INC. | 3.8% | |
| GENMAB A/S SPONSORED ADR | 3.7% | |
| BRIDGEBIO PHARMA, INC. | 3.3% | |
| IMMUNOME, INC. | 2.4% |
CANC Underweight Relative to XBI
| MODERNA, INC. | -2.0% | |
| VAXCYTE, INC. | -1.4% | |
| AMICUS THERAPEUTICS INC | -1.4% | |
| MIRUM PHARMACEUTICALS, INC. | -1.4% | |
| ALKERMES PLC | -1.4% | |
| KRYSTAL BIOTECH, INC. | -1.4% | |
| ROIVANT SCIENCES LTD. | -1.3% | |
| INCYTE CORP | -1.3% | |
| VERTEX PHARMACEUTICALS INC | -1.3% | |
| CYTOKINETICS INC | -1.3% |